IP Library Granted Patent US 9,040,771
Granted Patent B2
US 9,040,771 · App. 13/360,344 · Granted May 26, 2015

Nonhuman mammal whose mtDNA is from a nonhuman mammal resistant to a selected disease or disorder and whose nDNA is from a nonhuman donor mammal more susceptible to the selected disease or disorder

Inventors: Scott Webster Ballinger (Odenville, AL); Danny R. Welch (Vestavia Hills, AL); Robert Allen Kesterson (Birmingham, AL); Larry W. Johnson (Jasper, AL)
Assignee: The UAB Research Foundation
A01K67/0271A01K2217/00A01K2227/10A01K67/0273A01K2227/105A01K2267/0331A01K2267/0375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,771
App. No.
13/360,344
Granted
May 26, 2015
Kind
B2
Abstract

Provided herein are mitochondrial-nuclear exchanged cells and animals comprising mitochondrial DNA (mtDNA) from one subject and nuclear DNA (nDNA) from a different subject. Methods for producing a mitochondrial-nuclear exchanged animal and animals made by the methods are provided. Also provided are methods of screening for agents useful for treating a disease or disorder using mitochondrial-nuclear exchanged animals or cells, tissues or organs thereof.

Claims (7)

1. A nonhuman mammalian zygote or a nonhuman mammalian embryo whose cell or cells comprise mitochondrial DNA (mtDNA) from a first nonhuman donor mammal resistant to a selected disease or disorder and comprise nuclear DNA (nDNA) entirely from a second nonhuman donor mammal more susceptible to the selected disease or disorder compared to the first nonhuman mammal, wherein the donor resistant to the selected disease or disorder and the donor susceptible to the selected disease or disorder exhibit distinct mtDNA haplotypes.

2. The nonhuman mammalian zygote or nonhuman mammalian embryo of claim 1 , whose cell or cells comprise mtDNA entirely from a first nonhuman donor mammal resistant to the selected disease or disorder.

3. The zygote or embryo of claim 1 , wherein the disease or disorder is selected from the group consisting of cancer, cardiovascular disease, diabetes, neurological disorder, aging, metabolic disorder, immune disorder, obesity, and musculoskeletal disorder.

4. The embryo of claim 1 , wherein the embryo is a pro-nuclear embryo.

5. A nonhuman mammal that develops from the embryo of claim 1 , wherein the cells of the mammal comprise mtDNA from a first nonhuman donor mammal resistant to a selected disease or disorder and comprise nDNA entirely from a second nonhuman donor mammal more susceptible to the selected disease or disorder compared to the first nonhuman mammal, wherein the donor resistant to the selected disease or disorder and the donor susceptible to the selected disease or disorder exhibit distinct mtDNA haplotypes.

6. The nonhuman mammal of claim 5 , whose cells comprise mtDNA entirely from a first nonhuman donor mammal resistant to the selected disease or disorder.

7. The nonhuman mammal of claim 5 , wherein the mammal is a mouse comprising mtDNA from NZB/B1NJ mice.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 4, 2022
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY
Reel/Frame 058570/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2013
From: BALLINGER, SCOTT WEBSTER; WELCH, DANNY R.; KESTERSON, ROBERT ALLEN; JOHNSON, LARRY W.
To: THE UAB RESEARCH FOUNDATION
Reel/Frame 030083/0503 →
Continuity (3)
Continuation 12486375 · Jun 17, 2009
Provisional Application 61076260 · Jun 27, 2008
Related Publication 20140250542A1 · Sep 4, 2014